Selectivity of serotonergic drugs for multiple brain serotonin receptors. Role of [3H]-4-bromo-2,5-dimethoxyphenylisopropylamine ([3H]DOB), a 5-HT2 agonist radioligand.
Selectivity of serotonergic drugs for multiple brain serotonin receptors. Role of [3H]-4-bromo-2,5-dimethoxyphenylisopropylamine ([3H]DOB), a 5-HT2 agonist radioligand.
复制标题
血清素药物对多种脑血清素受体的选择性。
DOI:
10.1016/0006-2952(87)90643-5
复制
发表时间:
1987
影响因子:
5.8
通讯作者:
Glennon,RA
中科院分区:
文献类型:
--
作者:
Titeler,M;Lyon,RA;Davis,KH;Glennon,RA
The affinities of putative serotonin receptor agonists and antagonists for 5-HT 1A, 5-HT 1B, 5-HT 1C, and 5-HT 2 receptors were assayed using radioligand binding assays. The 5-HT 1 sites were labeled with the agonist radioligands [3 H]-8-hydroxy-2-(di-n-propylamino)-tetralin [3 H]-8-OH-DPAT,[3 H]-5-HT, and [3 H] mesulergine. The 5-HT 2 receptor was labeled with the antagonist radioligand [3 H] ketanserin or the agonist radioligand [3 H]-4-bromo-2, 5-dimethoxyphenylisopropylamine ([3 H] DOB). The apparent 5-HT 1 receptor selectivity of agonist compounds was found to be 50-to 100-fold higher when the 5-HT 2 receptor affinity was determined using the antagonist radioligand [3 H] ketanserin than when the agonist radioligand [3 H] DOB was used. Quipazine, a putative specific 5-HT 2 agonist, appeared to be only 3-fold more potent at 5-HT 2 than at 5-HT 1A receptors when [3 H] ketanserin was used as the 5-HT 2 radioligand. When [3 H] DOB was used as the 5-HT 2 radioligand, quipazine was determined to be 100-fold more potent at 5-HT 2 receptors than at 5-HT 1A receptors. 1-(3-trifluoromethylphenyl) piperazine (TFMPP), a putative specific 5-HT 1B receptor agonist was apparently 10-fold more potent at 5-HT 1B receptors than at 5-HT 2 receptors when [3 H] ketanserin was used as the 5-HT 2 radioligand. When [3 H] DOB was used as the 5-HT 2 radioligand, TFMPP was found to be equipotent at 5-HT 1B and 5-HT 2 receptors. Using the 5-HT 2 antagonist radioligand [3 H] ketanserin, a similar pattern of underestimating 5-HT 2 receptor selectivity and/or overestimating 5-HT 1A or 5-HT 1B receptor selectivity was observed for a series of serotonin receptor agonists. Antagonist receptor selectivity was not affected significantly by the nature of the 5-HT 2 receptor assay used. These data indicate that, by using an antagonist radioligand to label 5-HT 2 receptors and agonist radioligands to label 5-HT 1 receptors, the 5-HT 1 receptor selectivity may be overestimated. This may be an especially severe problem in serotonin drug development as drugs that interact potently with 5-HT 2 receptors have been reported to be psychoactive and/or hallucinogenic.
登录
查看更多内容
影响因子:
5
作者:
A. Basse;G. Rebec
通讯作者:
G. Rebec
影响因子:
3.6
作者:
L. Riblet;A. S. Eison;M. Eison;Duncan P. Taylor;D. Temple;C. P. Vandermaelen
通讯作者:
C. P. Vandermaelen
影响因子:
4.7
作者:
BATTAGLIA, G;SHANNON, M;TITELER, M
通讯作者:
TITELER, M
DOI:
--
发表时间:
1985
期刊:
The Journal of pharmacology and experimental therapeutics
影响因子:
--
作者:
Brady,LS;Barrett,JE
通讯作者:
Barrett,JE
影响因子:
5
作者:
HJORTH, S;CARLSSON, A
通讯作者:
CARLSSON, A